Value of Antibody Drug Conjugates for Gynecological Cancers: A Modern Appraisal Following Recent FDA Approvals
Author:
Publisher
Informa UK Limited
Subject
Maternity and Midwifery,Obstetrics and Gynecology,Oncology
Reference66 articles.
1. Cancer statistics, 2023
2. Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
3. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
4. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
5. Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ChatGPT compared to national guidelines for management of ovarian cancer: Did ChatGPT get it right? – A Memorial Sloan Kettering Cancer Center Team Ovary study;Gynecologic Oncology;2024-10
2. Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma;Gynecologic Oncology;2024-10
3. Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy;Journal of Ovarian Research;2024-08-08
4. Front-line chemoimmunotherapy for treating epithelial ovarian cancer: Part II promising results of phase 2 study of paclitaxel-carboplatin-oregovomab regimen;Taiwanese Journal of Obstetrics and Gynecology;2024-01
5. Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125;Taiwanese Journal of Obstetrics and Gynecology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3